| 常用名 | Ocrelizumab | CAS号 | 637334-45-3 |
|---|---|---|---|
| 价格 | 纯度 | 95.0% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Ocrelizumab is an anti-CD20 antibody that depletes circulating immature and mature B cells but spares CD20-negative plasma cells. The effector mechanisms of Ocrelizumab are complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity. Ocrelizumab is the first monoclonal antibody for secondary primary progressive multiple sclerosis (PPMS)[1]. 物理化学性质: CAS号:637334-45-3 常用中文名:Ocrelizumab 常用英文名:Ocrelizumab 分子式: 分子量: 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A |